164 related articles for article (PubMed ID: 15655055)
1. Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression.
Kraus MR; Schäfer A; Al-Taie O; Scheurlen M
J Viral Hepat; 2005 Jan; 12(1):96-100. PubMed ID: 15655055
[TBL] [Abstract][Full Text] [Related]
2. Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression.
Schäfer A; Scheurlen M; Seufert J; Keicher C; Weissbrich B; Rieger P; Kraus MR
J Hepatol; 2010 Jan; 52(1):10-5. PubMed ID: 19897271
[TBL] [Abstract][Full Text] [Related]
3. Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study.
Kraus MR; Schäfer A; Schöttker K; Keicher C; Weissbrich B; Hofbauer I; Scheurlen M
Gut; 2008 Apr; 57(4):531-6. PubMed ID: 18079286
[TBL] [Abstract][Full Text] [Related]
4. Effects of escitalopram prophylaxis during antiviral treatment for chronic hepatitis C in patients with a history of intravenous drug use and depression.
Hotho DM; Bezemer G; Hansen BE; Van Gool AR; de Knegt RJ; Janssen HL; Veldt BJ
J Clin Psychiatry; 2014 Oct; 75(10):1069-77. PubMed ID: 25188436
[TBL] [Abstract][Full Text] [Related]
5. Can antidepressants prevent pegylated interferon-α/ribavirin-associated depression in patients with chronic hepatitis C: meta-analysis of randomized, double-blind, placebo-controlled trials?
Hou XJ; Xu JH; Wang J; Yu YY
PLoS One; 2013; 8(10):e76799. PubMed ID: 24204676
[TBL] [Abstract][Full Text] [Related]
6. Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C.
Kraus MR; Schäfer A; Csef H; Scheurlen M
World J Gastroenterol; 2005 Mar; 11(12):1769-74. PubMed ID: 15793861
[TBL] [Abstract][Full Text] [Related]
7. Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C.
Kraus MR; Schäfer A; Faller H; Csef H; Scheurlen M
Aliment Pharmacol Ther; 2002 Jun; 16(6):1091-9. PubMed ID: 12030950
[TBL] [Abstract][Full Text] [Related]
8. Norepinephrine-enhancing antidepressant exposure associated with reduced antiviral effect of interferon alpha on hepatitis C.
Fialho R; Burridge A; Pereira M; Keller M; File A; Tibble J; Whale R
Psychopharmacology (Berl); 2016 May; 233(9):1689-94. PubMed ID: 25971875
[TBL] [Abstract][Full Text] [Related]
9. Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C.
Kraus MR; Al-Taie O; Schäfer A; Pfersdorff M; Lesch KP; Scheurlen M
Gastroenterology; 2007 Apr; 132(4):1279-86. PubMed ID: 17408646
[TBL] [Abstract][Full Text] [Related]
10. Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C.
Wang LJ; Chen SW; Chen CK; Yen CL; Chang JJ; Lee TS; Liu CJ; Chen LW; Chien RN
BMC Psychiatry; 2016 Nov; 16(1):424. PubMed ID: 27884134
[TBL] [Abstract][Full Text] [Related]
11. Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C.
de Knegt RJ; Bezemer G; Van Gool AR; Drenth JP; Hansen BE; Droogleever Fortuyn HA; Weegink CJ; Hengeveld MW; Janssen HL
Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1306-17. PubMed ID: 21999489
[TBL] [Abstract][Full Text] [Related]
12. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
Schaefer M; Sarkar R; Knop V; Effenberger S; Friebe A; Heinze L; Spengler U; Schlaepfer T; Reimer J; Buggisch P; Ockenga J; Link R; Rentrop M; Weidenbach H; Fromm G; Lieb K; Baumert TF; Heinz A; Discher T; Neumann K; Zeuzem S; Berg T
Ann Intern Med; 2012 Jul; 157(2):94-103. PubMed ID: 22801672
[TBL] [Abstract][Full Text] [Related]
13. DEPRESSIVE EPISODE INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN.
Vabo IL; Ferreira LE; Pace FH
Arq Gastroenterol; 2016; 53(1):20-4. PubMed ID: 27281500
[TBL] [Abstract][Full Text] [Related]
14. Triple antiviral re-therapy for chronic hepatitis C with interferon-alpha, ribavirin and amantadine in nonresponders to interferon-alpha and ribavirin.
Zilly M; Lingenauber C; Desch S; Väth T; Klinker H; Langmann P
Eur J Med Res; 2002 Apr; 7(4):149-54. PubMed ID: 12010649
[TBL] [Abstract][Full Text] [Related]
15. Association of interferon-alpha-induced depression and improved treatment response in patients with hepatitis C.
Loftis JM; Socherman RE; Howell CD; Whitehead AJ; Hill JA; Dominitz JA; Hauser P
Neurosci Lett; 2004 Jul; 365(2):87-91. PubMed ID: 15245784
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal effects of selective serotonin reuptake inhibitor therapy and cytokine-related depression on hepatitis C viral logs during antiviral therapy.
Sims OT; Whalen CC; Nackerud LG; Bride BE
J Clin Psychopharmacol; 2014 Feb; 34(1):80-4. PubMed ID: 24135839
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts.
Tseng PL; Chen TC; Chien YS; Hung CH; Yen YH; Chang KC; Tsai MC; Lin MT; Lee CT; Shen CH; Hu TH
Am J Kidney Dis; 2013 Oct; 62(4):789-95. PubMed ID: 23746377
[TBL] [Abstract][Full Text] [Related]
18. A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.
Neri S; Bertino G; Petralia A; Giancarlo C; Rizzotto A; Calvagno GS; Mauceri B; Abate G; Boemi P; Di Pino A; Ignaccolo L; Vadalà G; Misseri M; Maiorca D; Mastrosimone G; Judica A; Palermo F
J Clin Gastroenterol; 2010 Oct; 44(9):e210-7. PubMed ID: 20838237
[TBL] [Abstract][Full Text] [Related]
19. Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C.
Fontana RJ; Kronfol Z; Lindsay KL; Bieliauskas LA; Padmanabhan L; Back-Madruga C; Lok AS; Stoddard AM;
Am J Gastroenterol; 2008 Nov; 103(11):2766-75. PubMed ID: 18721241
[TBL] [Abstract][Full Text] [Related]
20. [Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection].
Hunyady B; Kovács B; Battyáni Z
Orv Hetil; 2011 Dec; 152(50):1997-2009. PubMed ID: 22112373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
